0001562180-20-005125.txt : 20200715
0001562180-20-005125.hdr.sgml : 20200715
20200715200654
ACCESSION NUMBER: 0001562180-20-005125
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200713
FILED AS OF DATE: 20200715
DATE AS OF CHANGE: 20200715
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: STACK DAVID M
CENTRAL INDEX KEY: 0001204788
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-21392
FILM NUMBER: 201030474
MAIL ADDRESS:
STREET 1: THE MEDICINES CO
STREET 2: 8 CAMPUS DRIVE
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMARIN CORP PLC\UK
CENTRAL INDEX KEY: 0000897448
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: X0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: SPACES SOUTH DOCKLANDS, BLOCK C
STREET 2: 77 SIR JOHN ROGERSON'S QUAY
CITY: DUBLIN 2
STATE: L2
ZIP: D02 VK60
BUSINESS PHONE: 353 1 6699 020
MAIL ADDRESS:
STREET 1: SPACES SOUTH DOCKLANDS, BLOCK C
STREET 2: 77 SIR JOHN ROGERSON'S QUAY
CITY: DUBLIN 2
STATE: L2
ZIP: D02 VK60
FORMER COMPANY:
FORMER CONFORMED NAME: AMARIN PHARMACEUTICALS PLC
DATE OF NAME CHANGE: 20000201
FORMER COMPANY:
FORMER CONFORMED NAME: ETHICAL HOLDINGS PLC
DATE OF NAME CHANGE: 19930322
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2020-07-13
false
0000897448
AMARIN CORP PLC\UK
AMRN
0001204788
STACK DAVID M
C/O AMARIN PHARMA, INC.
440 US HIGHWAY 22
BRIDGEWATER
NJ
08807
true
false
false
false
Stock Option (Right to Buy)
6.62
2020-07-13
4
A
false
34805.00
0.00
A
2030-07-13
Ordinary Shares
34805.00
34805.00
D
Restricted Stock Units
0.00
2020-07-13
4
A
false
27191.00
0.00
A
Ordinary Shares
27191.00
27191.00
D
On July 13, 2020, the Reporting Person was granted an option to purchase 34,805 Ordinary Shares under the Amarin Corporation plc 2020 Stock Incentive Plan (the "Plan"). The option shall vest and become exercisable in a single annual installment upon the earlier of (i) the anniversary of the grant date of July 13, 2020 or (ii) the Issuer's annual general meeting of shareholders in 2021.
The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
Each Restricted Stock Unit ("RSU") represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion, with settlement to be made on a deferred basis, specifically upon the non-employee director's separation of service with the Issuer.
On July 13, 2020, the Reporting Person was granted 27,191 RSUs under the Plan. The RSUs vest in equal annual installments over a three-year period, with each installment vesting upon the earlier of (i) the anniversary of the grant date of July 13, 2020 or (ii) the Issuer's annual general meeting of shareholders in such year.
Not applicable.
These grants are made in accordance with the Issuer's previously disclosed non-employee director compensation program. In the event of a Change of Control (as defined in the Plan), each of the grants described in this Form 4 vests in full. This number does not represent the aggregate number of Ordinary Shares of the Issuer this Reporting Person holds or has a right to acquire in the form of stock options and restricted stock units granted to such Reporting Person.
/s/ Joseph Kennedy, by power of attorney
2020-07-15